Sleep-disordered breathing technology company ResMed (ASX:RMD) has reported a 5% increase in profit and a 10% hike in revenue for the December quarter.

Amid the growing realisation that Australian research needs support to make it a reality, the Queensland Premier has pledged a "centrepiece" $90 million Research to Reality Fund if the LNP is returned in this weekend's election.

Evergreen private investment firm Manifex has opened of its second round of funding to help start-ups commercialise their high-tech products. Funding will be available to support companies that have developed technology in the advanced materials and advanced manufacturing sectors. [ + ]

Sienna Cancer Diagnostics CEO Dr Kerry Hegarty has resigned from the role after a 10-year term, as part of the company's strategic transformation plan.

Researchers from The Centenary Institute, Sydney, have announced a breakthrough in understanding the cause of stroke in young people. The leader of the research, Dr Xiangjian Zheng, said the stroke in question affects around five in every 1000 people, many of whom are diagnosed in their 30s and 40s. [ + ]

Troublesome jellyfish blooms may be better controlled by exploiting the finding that barrel jellyfish can detect the direction of ocean currents and swim strongly against them. [ + ]

Digital health is one of the strongest trends in healthcare and is transforming the delivery of healthcare around the world, including, but not limited to, digital applications (apps) and wearable technology. AusBiotech members are increasingly developing digital health technologies.

Professor Brendan Crabb, Professor John Funder and Professor Jeremy Chapman were awarded Companions of the Order of Australia in the Australia Day 2015 Honours List for their contributions to medicine.

Viralytics (ASX:VLA) has enrolled the first patient for a UK phase I trial of Cavatak in non-muscle invasive bladder cancer.

US biologists have proposed next-generation sequencing (NGS) as a way to provide fresh insight into populations' responses to a changing world. NGS, which makes it possible to analyse enormous numbers of short pieces of DNA very quickly, allows environmental biologists to assess the presence or absence of certain gene variants within local populations - which could point to selection for certain climate-adapted traits. [ + ]

Sigma-Aldrich's Research business unit has formed an alliance with VIB, a Belgium-based life science research institute, in a move that will focus on the commercialisation and supply of new tools and technologies to help meet the evolving needs of translational researchers. [ + ]

The spread of antibiotic-resistant strains of tuberculosis conincided with the Industrial Revolution and the collapse of the Soviet Union. [ + ]

AusBiotech is seeking expressions of interest to join the Australian delegation to the 73rd China International Medical Equipment Fair (CMEF), to be held in Shanghai, China, from 15-18 May 2015.

A smart inhaler developed by Nexus6 improves medication adherence in child asthmatics and reduces their reliance on rescue medication.

Clinuvel (ASX:CUV) has named B&S International founder William Blijdorp as a non-executive director, to help assist with the European commercialisation of Scenesse in erythropoietic protoporphyria.